Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 39Lymphoid 38Myeloid 10Plasma cell 3Dermatologic 3Sarcoma 2CNS 2Breast 2Other neoplasm 1Other 1Head & Neck 1Classical hematology 1

Conditions

Neurotoxicity Syndromes 1Mucositis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1

Interventions

Radiotherapy 3Cisplatin 2glucarpidase 1exemestane 1apraglutide 1Therapeutics 1Surveys and Questionnaires 1Quercetin 1Methotrexate 1Leuprolide 1Leucovorin 1Letrozole 1Hydroxychloroquine 1Goserelin 1Gonadotropin-Releasing Hormone 1Fibroblast Growth Factor 7 1Fentanyl 1Curcumin 1Bupropion 1Aromatase Inhibitors 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Methotrexate × Other × Clear all
NCT00727831 2014-01-27

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

University College, London

Phase 1/2 Completed
4 enrolled
LymphoidOther

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Neurotoxicity Syndromes, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡